3414-94-6Relevant articles and documents
Synthesis, structural characterization, electrochemical studies and DFT calculations on nickel(II) complexes of N-picolinoyl-N′-benzothioylhydrazide and 5-(pyridine-4-yl)-2H-1,2,4-triazole-3-thione
Bharty,Kushawaha,Chaudhari,Dani,Maiti,Butcher
, p. 243 - 252 (2017)
Two Ni(II) complexes, [Ni(pbth)2] and [Ni(ptt)2(en)2] {Hpbth?=?N-picolinoyl-N′-benzothioylhydrazide, Hptt?=?5-(pyridine-4-yl)-2H-1,2,4-triazole-3-thione} have been synthesized and characterized by physico-chemical and spectroscopic methods. [Ni(pbth)2] contains a pair of N-picolinoyl-N′-benzothioylhydrazide ligands coordinated via their thione sulfur, pyridyl nitrogen and hydrazinic nitrogen atoms, forming two C2N2Ni and two CSN2Ni five-membered chelate rings. The intermediate compound 1-isonicotinoyl-3-thiosemicarbazide is converted to 5-(pyridine-4-yl)-2H-1,2,4-triazole-3-thione in the presence of ethanolic NaOH, giving the complex [Ni(ptt)2(en)2] in which the ptt ligands coordinate through their triazole ring nitrogen atoms, while four more nitrogens from two ethylenediamine ligands complete the octahedral structure. The crystal structures of the complexes involve various types of intermolecular extended hydrogen bonds, forming supramolecular frameworks. Cyclic voltammetry studies of both complexes show quasi-reversible redox behavior. Density Functional Theory electronic structure calculations corroborate our experimental findings.
Novel panaxadiol triazole derivatives induce apoptosis in HepG-2 cells through the mitochondrial pathway
Xiao, Shengnan,Wang, Xude,Xu, Lei,Li, Tao,Cao, Jiaqing,Zhao, Yuqing
, (2020/07/23)
In this study, we introduced 1, 2, 4-triazole groups into panaxadiol (PD) to obtain 18 panaxadiol triazole derivatives. Five cancer cells and one normal cell were evaluated for cytotoxicity by MTT assay. The results showed that most of the derivatives could inhibit cancer cell proliferation, and the anti-proliferative activity of compound A1 was the most significant. For HepG-2 cells, the IC50 value was 4.21 ± 0.54 μM, which was nearly 15 times higher than the activity of PD. Further studies showed that compound A1 could induce apoptosis in HepG-2 cells, and could enhance the expression of Cl-caspase-3, Cl-caspase-9 and Cl-PARP. Moreover, Western blot analysis showed that after treating HepG-2 cells with compound A1, the expression of p53 protein was increased and the ratio of Bax/Bcl-2 was gradually increased. The cytoplasmic Bax is then translocated to the mitochondria, causing the release of Cyt c protein. Therefore, the results indicate that compound A1 induces apoptosis through the mitochondrial pathway and can be used the potential to develop new anti-proliferative agents.
Structure-activity relationships of triazole-benzodioxine inhibitors of cathepsin X
Fonovi?, Ur?a Pe?ar,Gobec, Stanislav,Hrast, Martina,Knez, Damijan,Kos, Janko,Proj, Matic,Zidar, Nace
, (2020/03/24)
Cathepsin X is a cysteine carboxypeptidase that is involved in various physiological and pathological processes. In particular, highly elevated expression and activity of cathepsin X has been observed in cancers and neurodegenerative diseases. Previously, we identified compound Z9 (1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-((4-isopropyl-4H-1,2,4-triazol-3-yl)thio)ethan-1-one) as a potent and specific reversible cathepsin X inhibitor. Here, we have explored the effects of chemical variations to Z9 of either benzodioxine or triazol moieties, and the importance of the central ketomethylenethio linker. The ketomethylenethio linker was crucial for cathepsin X inhibition, whereas changes of the triazole heterocycle did not alter the inhibitory potencies to a greater extent. Replacement of benzodioxine moiety with substituted benzenes reduced cathepsin X inhibition. Overall, several synthesized compounds showed similar or improved inhibitory potencies against cathepsin X compared to Z9, with IC50 values of 7.1 μM–13.6 μM. Additionally, 25 inhibited prostate cancer cell migration by 21%, which is under the control of cathepsin X.
